Interferon-alpha therapy in chronic myelogenous leukemia: questions related to the German randomized trial.
Kantarjian
H M
HM
Talpaz
M
M
D001772:Blood Cell Count; D004305:Dose-Response Relationship, Drug; D005858:Germany; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D011379:Prognosis; D016019:Survival Analysis
D016898:Interferon-alpha